InvestorsHub Logo
Followers 17
Posts 936
Boards Moderated 0
Alias Born 04/26/2010

Re: To infinity and beyond! post# 241448

Monday, 09/17/2018 9:36:21 PM

Monday, September 17, 2018 9:36:21 PM

Post# of 403047
It seems that I am wasting my time. One final point. I think it was more out of fear of possible failure of Brilacidin when compared to Galera's drug that IPIX may have waited for more details from GC4419 trial. No strategic plans, just plain old fear of failure; why would FDA grant a BTD for an inferior drug to one they just awarded the designation.

"I would rather have questions that can't be answered than answers that can't be questioned." Richard P. Feynman

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News